Research location
Ballarat
Victoria, Australia
Advertisement
Research activity in Ballarat
Victoria, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 47 trials and 48 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ballarat
47 linked trials · page 1 of 1A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative CancerNCT07358377 · 2026-05-15 · 1 site observation
RECRUITING
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsNCT07262619 · 2026-01-20 · 1 site observation
RECRUITING
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNCT07472517 · 2025-11-07 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)NCT07144280 · 2025-09-29 · 1 site observation
RECRUITING
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)NCT06623422 · 2024-10-21 · 1 site observation
RECRUITING
Working Out M0 Bipolar Androgen TherapyNCT06594926 · 2024-08-14 · 1 site observation
RECRUITING
National Robotics-Assisted Radical Prostatectomy DatabaseNCT06279260 · 2024-07-01 · 1 site observation
RECRUITING
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) TrialNCT05072314 · 2022-07-27 · 2 site observations
RECRUITING
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207 · 2024-04-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosisNCT05752279 · 2024-03-14 · 1 site observation
COMPLETED
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerNCT06318273 · 2024-03-08 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung CancerNCT05800015 · 2023-08-08 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05785767 · 2023-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART)NCT04622007 · 2021-06-02 · 1 site observation
UNKNOWN
A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung CancerNCT04746924 · 2021-05-24 · 1 site observation
TERMINATED
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)NCT04623775 · 2021-02-17 · 1 site observation
COMPLETED
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and ChemotherapyNCT04655976 · 2020-12-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung CancerNCT04475939 · 2020-10-26 · 1 site observation
COMPLETED
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
LYT-100 in Patients With BCRLNCT04243837 · 2020-03-01 · 1 site observation
TERMINATED
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate CancerNCT04100018 · 2020-02-06 · 1 site observation
COMPLETED
Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)NCT03829319 · 2019-03-25 · 1 site observation
COMPLETED
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)NCT03740165 · 2018-12-18 · 1 site observation
COMPLETED
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)NCT03631784 · 2018-10-19 · 1 site observation
COMPLETED
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast CancerNCT02889874 · 2017-08-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)NCT03179436 · 2017-07-02 · 1 site observation
COMPLETED
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung CancerNCT03098030 · 2017-06-01 · 1 site observation
COMPLETED
Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)NCT03061812 · 2017-04-11 · 1 site observation
COMPLETED
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLCNCT03057106 · 2017-03-28 · 1 site observation
ACTIVE_NOT_RECRUITING
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyNCT03078036 · 2017-03-13 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)NCT02657434 · 2016-04-30 · 1 site observation
COMPLETED
A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)NCT02677896 · 2016-03-09 · 1 site observation
COMPLETED
Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 1 site observation
COMPLETED
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With EnzalutamideNCT01977651 · 2013-09-25 · 1 site observation
COMPLETED
Major Depressive Disorder - Understanding The Link Between The Brain And The HeartNCT01568307 · 2012-05-01 · 1 site observation
COMPLETED
Alleviating the Metabolic Side Effects of Antipsychotic MedicationsNCT01567124 · 2012-05-01 · 1 site observation
WITHDRAWN
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseNCT00710684 · 2008-07-01 · 1 site observation
COMPLETED
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.NCT00731224 · 2008-07-01 · 1 site observation
COMPLETED
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsNCT00667810 · 2008-06-01 · 1 site observation
TERMINATED
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsNCT00676143 · 2008-01-01 · 1 site observation
TERMINATED
Chemotherapy in Treating Patients With Non-Small Cell Lung CancerNCT00520676 · 2007-10-01 · 1 site observation
COMPLETED
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone MetastasesNCT00434447 · 2006-12-01 · 1 site observation
COMPLETED
PROFIT - Prostate Fractionated Irradiation TrialNCT00304759 · 2006-05-01 · 1 site observation
COMPLETED
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast CancerNCT00068601 · 2003-10-01 · 1 site observation
COMPLETED
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.NCT00151502 · 2002-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.